Why We Invested In Signos – Weight Loss Built For You

2 min read

  Excited to announce the $13M series A led by GV in Signos, which helps you lose weight through continuous glucose monitoring (CGM). Tau Ventures had first invested alongside Courtside Ventures and 1984.vc in the unannounced $4M seed. We are an AI-first fund in Silicon Valley investing primarily in seed and occasionally take later bets when we see immense promise. “Signos” has a number of meanings paying homage to the company’s mission. For instance in Spanish it means “signs” which evokes signals and communication to help you understand your body’s language. The company was founded in 2018 and impressed us…...

This article is free to read

Login to read the full article


OR

By subscribing to our main site, you will also be subscribed to DDIntel - our regular letter showcasing our featured articles and applications.

Amit Garg I have been in Silicon Valley for 20 years -- at Samsung NEXT Ventures, running my own startup (as of May 2019 a series D that has raised $120M and valued at $450M), at Norwest Ventures, and doing product and analytics at Google. My academic training is BS in computer science and MS in biomedical informatics, both from Stanford, and MBA from Harvard. I speak natively 3 languages, live carbon-neutral, am a 70.3 Ironman finisher, and have built a hospital in rural India serving 100,000 people.